© 2024 Corcept Therapeutics, Incorporated
25+ YEARS, 1,000+ NOVEL MOLECULES
We’ve been unlocking the potential of cortisol modulation for more than 25 years.
We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advance the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
We are the ripples of change.
25+
years of research
30+
studies underway
1000+
novel molecules
400+
people collaborating in pursuit of science
A global network of dedicated hands and minds focused on unlocking the possibilities of cortisol modulation to revolutionize the treatment of serious diseases. We are the ripples of change in cortisol modulation and we embrace possibility.
underway
of research
molecules
collaborating in
pursuit of science
How we work.
Collaborate
Our company is built upon cooperation and mutual success. It’s through these partnerships that we will change the world of medicine.
Embrace Possibility
Big ideas are not often evident at first glance; that’s why we encourage each other to be guided by curiosity and explore new possibilities.
Follow the Data
We always follow the data to pursue our north star of identifying and addressing the most critical patient needs.
Lead By Doing
By collaborating, embracing possibility and following the data, we work every day to drive the field of cortisol modulation forward.
Collaborate
Our company is built upon cooperation and mutual success. It’s through these partnerships that we will change the world of medicine.
Embrace Possibility
Big ideas are not often evident at first glance; that’s why we encourage each other to be guided by curiosity and explore new possibilities.
Follow the Data
We always follow the data to pursue our North Star of identifying and addressing the most critical patient needs.
Lead By Doing
By collaborating, embracing possibility and following the data, we work every day to drive the field of cortisol modulation forward.